COHANCE
Invest with MTF
Invest Now
Invest in Cohance Lifesciences with 2.86X leverage
Performance
- Low
- ₹379
- High
- ₹388
- 52 Week Low
- ₹379
- 52 Week High
- ₹1,328
- Open Price₹387
- Previous Close₹387
- Volume380,413
- 50 DMA₹539.51
- 100 DMA₹655.66
- 200 DMA₹788.65
Investment Returns
- Over 1 Month -29.31%
- Over 3 Month -57.52%
- Over 6 Month -64.17%
- Over 1 Year -62.72%
Smart Investing Starts Here Start SIP with Cohance Lifesciences for Steady Growth!
Cohance Lifesciences Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 58.9
- PEG Ratio
- 30.2
- Market Cap Cr
- 14,599
- P/B Ratio
- 3.9
- Average True Range
- 15.99
- EPS
- 8.98
- Dividend Yield
- 0
- MACD Signal
- -37.67
- RSI
- 9.52
- MFI
- -
Cohance Lifesciences Financials
Cohance Lifesciences Technicals
EMA & SMA
Current Price
₹381.60
-5.25
(-1.36%)
- Bearish Moving Average 16
- Bullish Moving Average 0
- 20 Day
- ₹455.46
- 50 Day
- ₹539.51
- 100 Day
- ₹655.66
- 200 Day
- ₹788.65
Resistance and Support
382.93
- R3 395.47
- R2 391.73
- R1 386.67
- S1 377.87
- S2 374.13
- S3 369.07
Cohance Lifesciences Corporate Actions - Bonus, Splits, Dividends
Cohance Lifesciences F&O
About Cohance Lifesciences
- NSE Symbol
- COHANCE
- BSE Symbol
- 543064
- Managing Director
- Dr. V Prasada Raju
- ISIN
- INE03QK01018
Similar Stocks to Cohance Lifesciences
Cohance Lifesciences FAQs
Cohance Lifesciences share price is ₹381 As on 23 January, 2026 | 19:42
The Market Cap of Cohance Lifesciences is ₹14598.8 Cr As on 23 January, 2026 | 19:42
The P/E ratio of Cohance Lifesciences is 58.9 As on 23 January, 2026 | 19:42
The PB ratio of Cohance Lifesciences is 3.9 As on 23 January, 2026 | 19:42
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.